Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acasti Pharma
Acasti Pharma
(ACST)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Microcrystalline cellulose
follicular lymphoma
,
large b-cell lymphoma diffuse
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
lymphoma
,
non-hodgkin lymphoma
,
t-cell lymphoma
,
t-cell lymphoma peripheral
,
myelodysplastic syndromes
,
myeloproliferative disorders
,
multiple myeloma
,
hematologic diseases
,
anemia
,
hodgkin disease
,
aplastic anemia
,
preleukemia
,
myeloid leukemia chronic-phase
,
b-cell leukemia
,
infections
,
communicable diseases
,
infectious skin diseases
,
skin diseases
,
bacterial infections
,
soft tissue infections
,
recurrence
,
glioblastoma
,
respiratory tract infections
,
sinusitis
,
type 2 diabetes mellitus
,
chronic renal insufficiency
,
renal insufficiency
,
metabolic diseases
,
metabolic bone diseases
,
hyperphosphatemia
,
bone diseases
,
bacterial skin diseases
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use